Announcements Trials
Browse Landscape

Phase

Phase 2 66Phase NA 45Phase 1 37Phase 3 25Phase 1/2 15Phase 2/3 5Phase EARLY_PHASE1 2Phase 4 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 35Ovarian Neoplasms 31Endometrial Neoplasms 13Uterine Cervical Dysplasia 10Papillomavirus Infections 9Breast Neoplasms 9Uterine Neoplasms 7Ovarian Cysts 6Lung Neoplasms 6Stomach Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Polycystic Ovary Syndrome 3Ovarian Hyperstimulation Syndrome 3Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Vomiting 2Uterine Diseases 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Squamous Intraepithelial Lesions 2Small Cell Lung Carcinoma 2Recurrence 2Peritoneal Neoplasms 2Pancreatic Neoplasms 2

Interventions

Hyperthermic Intraperitoneal Chemotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Peritoneal Neoplasms × Gynecologic × Clear all
NCT01932125 2025-06-26

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Hoffmann-La Roche

Phase 4 Completed
100 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT05250648 2024-10-09

GECOP-MMC

Hospital Universitario de Fuenlabrada

Phase 4 Recruiting
216 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡